Selling AAA in Europe
This article was originally published in The Gray Sheet
Executive Summary
Edwards Lifesciences will distribute Endologix' PowerLink abdominal aortic aneurysm stent graft in Belgium, France, Germany and the UK. PowerLink received CE mark in 1999. A PMA is pending at FDA, and the firm expects approval during the second half of the year. Endologix plans to create a direct sales force for U.S. commercialization. Edwards recently abandoned its LifePath AAA program after unsuccessfully seeking a buyer (1"The Gray Sheet" April 12, 2004, In Brief)...